Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

Publications
Nov 2025
Jeremiah Helm and Sean Murray’s Discuss Extension of Printed Matter Doctrine in Law360 Column
In their latest Law360 column discussing noteworthy Federal Circuit cases, partners Jeremiah Helm and Sean Murray examine the recent decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., and how...
Blog - Biotechnology
Oct 2025
USPTO, JPO, and EPO Meet to Discuss Global IP Challenges
Beginning on October 20, 2025, recently confirmed United States Patent and Trademark Office (USPTO) Director John A. Squires met with European Patent Office (EPO) Vice-President Steve Rowan and Japanese Patent...
News
Nov 2025
Knobbe Martens Recognized Among Top-Tier Firms in Best Law Firms Annual Guide
Firm receives ‘Tier 1’ national and regional rankings for litigation, patent and trademark work IRVINE, Calif., November 6, 2025 – Knobbe Martens has once again been recognized as a top-tier...